Translational assessment of a DATA-functionalized FAP inhibitor with facile
CAF
FAP inhibitors
PET imaging
Tumor stroma
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
30
01
2023
accepted:
19
05
2023
medline:
5
10
2023
pubmed:
7
6
2023
entrez:
7
6
2023
Statut:
ppublish
Résumé
The present study aims at evaluating the preclinical and the clinical performance of [ [ [ The radiochemical, preclinical, and clinical data obtained in this study strongly support further development of [
Identifiants
pubmed: 37284857
doi: 10.1007/s00259-023-06285-2
pii: 10.1007/s00259-023-06285-2
pmc: PMC10541845
doi:
Substances chimiques
Gallium Radioisotopes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3202-3213Subventions
Organisme : ESKAS
ID : 2021-2022
Informations de copyright
© 2023. The Author(s).
Références
J Nucl Med. 2018 Sep;59(9):1415-1422
pubmed: 29626119
Exp Mol Pathol. 2013 Dec;95(3):350-56
pubmed: 24422232
J Nucl Med. 2018 Sep;59(9):1423-1429
pubmed: 29626120
Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3651-3667
pubmed: 35608703
Pharmaceuticals (Basel). 2022 Aug 14;15(8):
pubmed: 36015148
J Nucl Med. 2021 Jun 1;62(6):779-786
pubmed: 33097632
Clin Exp Metastasis. 2011 Aug;28(6):567-79
pubmed: 21604185
Front Oncol. 2020 Jul 08;10:979
pubmed: 32733792
Int J Biochem Cell Biol. 2004 Nov;36(11):2320-33
pubmed: 15313476
ChemMedChem. 2015 Jun;10(6):1019-26
pubmed: 25899500
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):942-944
pubmed: 32783111
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1915-1931
pubmed: 33244617
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3918-3924
pubmed: 34018010
J Nucl Med. 2013 Jun;54(6):855-60
pubmed: 23516312
Int J Cancer. 2020 Feb 15;146(4):895-905
pubmed: 30734283
Cancer Res. 2002 Aug 15;62(16):4767-72
pubmed: 12183436
Tumour Biol. 2016 Oct;37(10):13961-13971
pubmed: 27492457
J Nucl Med. 2020 Dec;61(12):1806-1813
pubmed: 32332144
J Invest Dermatol. 2003 Feb;120(2):182-8
pubmed: 12542520
Nuklearmedizin. 2021 Oct;60(5):344-354
pubmed: 34256394
Cancer Res. 2010 Sep 1;70(17):6945-56
pubmed: 20699369
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):721-731
pubmed: 34342669
Cancers (Basel). 2021 Mar 04;13(5):
pubmed: 33806468
J Nucl Med. 2020 Apr;61(4):563-569
pubmed: 31586001
BMC Cancer. 2011 Jun 13;11:245
pubmed: 21668992
Pharmaceuticals (Basel). 2021 Oct 05;14(10):
pubmed: 34681246
J Nucl Med. 2013 Oct;54(10):1755-9
pubmed: 23929824
J Nucl Med. 2022 Jun;63(6):862-868
pubmed: 34556528
Mol Imaging Biol. 2021 Oct;23(5):686-696
pubmed: 33721173
Appl Radiat Isot. 2020 Feb;156:108867
pubmed: 31883763
Eur J Radiol. 2020 Jun;127:109021
pubmed: 32344293
J Nucl Med. 2022 Mar;63(3):415-423
pubmed: 34168013
BMC Cancer. 2020 Oct 27;20(1):1032
pubmed: 33109151
EJNMMI Radiopharm Chem. 2020 Jul 29;5(1):19
pubmed: 32728930
Molecules. 2021 Jun 08;26(12):
pubmed: 34201111
Biomark Res. 2020 Nov 11;8(1):64
pubmed: 33292666
J Nucl Med. 2019 Oct;60(10):1421-1429
pubmed: 30850501
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):385-389
pubmed: 34226953
Blood. 2006 Feb 15;107(4):1397-404
pubmed: 16223769
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1611-20
pubmed: 27260521
J Nucl Med. 2020 Aug;61(8):1171-1177
pubmed: 31836685
J Nucl Med. 2019 Mar;60(3):386-392
pubmed: 30072500
Nuklearmedizin. 2020 Sep;59(5):387-389
pubmed: 32392592
EJNMMI Radiopharm Chem. 2019 Jul 25;4(1):16
pubmed: 31659499
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
Clin Cancer Res. 2003 May;9(5):1639-47
pubmed: 12738716
J Med Chem. 2014 Apr 10;57(7):3053-74
pubmed: 24617858
Br J Haematol. 2006 Apr;133(1):83-92
pubmed: 16512833
J Nucl Med. 2020 Oct;61(10):1507-1513
pubmed: 32169911